interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Drug shortage outlook › Triamcinolone Hexacetonide

Shortage outlook · all drugs · read October 2026

How long has Triamcinolone Hexacetonide been on the FDA shortage list?

Triamcinolone Hexacetonide has been on the FDA shortage list for 5 years and 6 months. 45 of the 397 listings measured since 2014 lasted at least that long. Of the 45 past listings that reached the same age, 85% were still listed 6 months later (33 listings measured). These are counts of listings, not a forecast.

Compiled by Vincent Wesley Couey (ORCID 0009-0005-6869-308X). FDA list read October 2026.

Not medical advice. A listing is what the FDA published, not a measure of what your pharmacy can supply. Do not use this page to decide whether to start, stop or change a medicine. Ask your pharmacist or prescriber, and see FDA drug shortage information for current notices.
Triamcinolone Hexacetonideon the FDA shortage list now
66months listed

Triamcinolone Hexacetonide has been on the FDA shortage list for 5 years and 6 months (May 2021 to October 2026).

  1. 45 of the 397 listings measured since 2014 lasted at least that long.
  2. Of the 45 past listings that reached the same age, 85% were still listed 6 months later (33 listings measured).
  3. Triamcinolone Hexacetonide has been listed 2 times since 2014: earlier listings lasted 1 year and 11 months.
  4. None of this predicts an end date. A listing ends when the FDA removes it, which reflects supply across the whole country, and says nothing about one pharmacy's shelf.

The listing history, to scale

  1. Triamcinolone Hexacetonide Injectable suspensionListed October 2014 to August 2016 · 1 year and 11 months
  2. Triamcinolone Hexacetonide Injectable suspensionListed since May 2021 · 5 years and 6 months

What past listings of this age did

Of past listings that had already run 5 years and 6 months, how many were still listed later?

After 6 more months85%33 listings measured
After 12 more monthstoo few listings to show a share27 listings measured
After 24 more monthstoo few listings to show a share20 listings measured

What the FDA list says about it today

1presentations listed
1company
4 May 2021first posted

None of the 1 presentations states a reason. FDA category: Rheumatology.

Company by company

Of 1 presentations, the companies reported 1 available, 0 with limited availability and 0 unavailable. This is each company's own report to the FDA, with the date of its last update.

  • Medexus1 presentation · last updated 15 September 2026

FDA shortage list read October 2026 (monthly archived copies since 2014, rebuilt in the published dataset; current listing file read 11 November 2026). Listing is the FDA's status, not a statement about any pharmacy.

Where can you go from this result?

This result is one of 61 drugs on the list now. Open it in the lookup to search another drug, or read how the listings were measured.

To check what is available now, ask your pharmacist, and see FDA drug shortage information and the FDA drug shortages database.